StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
GSK plc
LSE:GSK.L
Sector
Location
Market Cap
USD 77.89 B
Share Price
USD 19.21
Avg Daily Volume
10,453,685
Change (1 day)
-1.02%
Change (1 year)
0.74%
Change (YTD)
14.05%
GSK plc Debt to Equity Ratio for the year ending December 31, 2024: 1.24
GSK plc Debt to Equity Ratio is 1.24 for the year ending December 31, 2024, a -7.96% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
-
GSK plc Debt to Equity Ratio for the year ending December 31, 2023 was 1.35, a -31.83% change year over year.
-
GSK plc Debt to Equity Ratio for the year ending December 31, 2022 was 1.98, a 23.33% change year over year.
-
GSK plc Debt to Equity Ratio for the year ending December 31, 2021 was 1.61, a -13.73% change year over year.
-
GSK plc Debt to Equity Ratio for the year ending December 31, 2020 was 1.86, a -26.89% change year over year.
Competitors
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
Cencora, Inc.
USD 291.17
COR
-4.16
-1.41%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.29
600276.SS
-0.03
-0.39%
Takeda Pharmaceutical Company Limited
USD 30.65
4502.T
-0.23
-0.74%
Haleon plc
USD 5.08
HLN.L
-0.08
-1.63%
Daiichi Sankyo Company, Limited
USD 22.61
4568.T
-0.33
-1.46%
UCB SA
USD 196.68
UCB.BR
-0.30
-0.15%
Hansoh Pharmaceutical Group Company Limited
USD 3.92
3692.HK
+0.07
1.85%
Teva Pharmaceutical Industries Limited
USD 16.99
TEVA.TA
+0.26
1.55%
Key Data
| Date | Debt to Equity Ratio | Quick Ratio | Current Ratio | Interest Coverage Ratio |
|---|
Competitors
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
Cencora, Inc.
USD 291.17
COR
-4.16
-1.41%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.29
600276.SS
-0.03
-0.39%
Takeda Pharmaceutical Company Limited
USD 30.65
4502.T
-0.23
-0.74%
Haleon plc
USD 5.08
HLN.L
-0.08
-1.63%
Daiichi Sankyo Company, Limited
USD 22.61
4568.T
-0.33
-1.46%
UCB SA
USD 196.68
UCB.BR
-0.30
-0.15%
Hansoh Pharmaceutical Group Company Limited
USD 3.92
3692.HK
+0.07
1.85%
Teva Pharmaceutical Industries Limited
USD 16.99
TEVA.TA
+0.26
1.55%